跳至主要内容
临床试验/JPRN-UMIN000028190
JPRN-UMIN000028190已完成未知

Exploratory trial to examine the safety and effectiveness of transdermal electrical stimulation for retinitis pigmentosa - Exploratory trial to examine the safety and effectiveness of transdermal electrical stimulation for retinitis pigmentosa

Chiba university hospital0 个研究点目标入组 10 人开始时间: 2017年7月12日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • cases who conflict with any of the following must not include this study. (1) Patients complicated of macular lesions such as vitreous macular traction syndrome, macular edema, epiretinal membrane, and myopia with posterior staphyloma associated with myopia (2) Patients undergoing internal eye surgery within 3 months (3) Patients who changed the dose and usage of isopropyl unoprostone, calcium antagonist, dark adaptation improving drug within 31 days before screening (4) Patients who have a history of drug allergy to drugs to be used during the trial period (mydriatic drugs, eye drops anesthetics, etc.) (5) Patients complicated with diabetic retinopathy (6) Patients who are currently complaining of external eye inflammation, infection, or severe dry eye (7) Patients who may be pregnant or pregnant. Patient who is breastfeeding. Patients who want pregnancy during the trial period (8) Patients with a history of optic nerve disease (9) Evaluation of efficacy nuclear cataract with moderate degree (grade 3 in Emery classification) to the eyes, patients with complication of anterior subcapsular, subcapsular cataract, or late cataract which have a serious effect on vision (10) Patients whose Mean Deviation (MD) value of HFA 10-2 has deteriorated by 3 dB or more per year (11) Patients who have not seen any deterioration in visual acuity, OCT findings, dynamic visual field inspection (Gp) findings, and visual field sensitivities at HFA 10-2 in the last 3 years (12) Patients currently participating in other clinical trials (13) patients under investigational responsibility (shared) doctors judged inappropriate for participation in this trial

研究者

相似试验